Publication | Closed Access

Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge

InflammationAllergen ChallengeAllergyInflammatory Lung DiseaseLung InflammationAirway HyperresponsivenessImmunologyFibroblast Growth FactorMedicinePulmonary Disease